Literature DB >> 17488270

A rate-independent method of assessing QT-RR slope following conversion of atrial fibrillation.

Dawood Darbar1, Bradley Hardin, Paul Harris, Dan M Roden.   

Abstract

INTRODUCTION: Following conversion of atrial fibrillation (AF), QT interval transiently and variably prolongs and can trigger torsades de pointes (TdP). However, quantitative analysis of risk in this setting is difficult because cycle length variability during AF makes rate-corrected QT impossible to calculate. In this study, a newly developed method to study heart rate dependence of the QT interval during AF was applied to assess the QT-RR relationships prior to and following cardioversion in patients with AF. METHODS AND
RESULTS: Cardiac rhythm was digitized for > or = 30 minutes prior to and following elective cardioversion to sinus rhythm (SR) in 12 patients. Each QT interval was placed in a "bin" (50 ms), according to the preceding RR interval. All QT intervals within a bin were averaged and RR bin-specific QT values were derived. The slope of the QT-RR relationship was much flatter in AF (0.058 +/- 0.02) compared with that predicted by conventionally used QT rate corrections (0.130 [Bazett], 0.096 [Fridericia]) and much steeper after cardioversion (0.238 +/- 0.14, P < 0.01 compared with AF). The method also allowed us to establish that QT at any given RR interval prolonged when SR was restored (e.g., at RR interval 800 ms: QT = 0.38 +/- 0.03 second [AF] vs 0.46 +/- 0.05 second [SR], P < 0.01). The longest QT values were in patients receiving sotalol or quinidine.
CONCLUSIONS: The results of this study demonstrate that QT interval can be reliably measured in AF using a method that is independent of heart rate. We also showed that cardioversion of AF acutely increases the QT interval and the steepness of the QT-RR slope.

Entities:  

Mesh:

Year:  2007        PMID: 17488270     DOI: 10.1111/j.1540-8167.2007.00817.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  8 in total

Review 1.  Drug-induced long QT syndrome.

Authors:  Prince Kannankeril; Dan M Roden; Dawood Darbar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Enhanced sensitivity to drug-induced QT interval lengthening in patients with heart failure due to left ventricular systolic dysfunction.

Authors:  James E Tisdale; Brian R Overholser; Heather A Wroblewski; Kevin M Sowinski; Kwadwo Amankwa; Steven Borzak; Joanna R Kingery; Rita Coram; Douglas P Zipes; David A Flockhart; Richard J Kovacs
Journal:  J Clin Pharmacol       Date:  2011-11-01       Impact factor: 3.126

3.  Rate-independent QT shortening during exercise in healthy subjects: terminal repolarization does not shorten with exercise.

Authors:  Prince J Kannankeril; Paul A Harris; Kris J Norris; Irfan Warsy; Phillip D Smith; Dan M Roden
Journal:  J Cardiovasc Electrophysiol       Date:  2008-07-28

4.  Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome.

Authors:  Dawood Darbar; John Kimbrough; Asif Jawaid; Robert McCray; Marylyn D Ritchie; Dan M Roden
Journal:  J Am Coll Cardiol       Date:  2008-02-26       Impact factor: 24.094

Review 5.  Proarrhythmic and Torsadogenic Effects of Potassium Channel Blockers in Patients.

Authors:  Mark McCauley; Sharath Vallabhajosyula; Dawood Darbar
Journal:  Card Electrophysiol Clin       Date:  2016-03-22

6.  Recent heart rate history affects QT interval duration in atrial fibrillation.

Authors:  Fady S Riad; Eathar Razak; Samir Saba; Alaa Shalaby; Jan Nemec
Journal:  PLoS One       Date:  2017-03-08       Impact factor: 3.240

7.  Information transfer in QT-RR dynamics: Application to QT-correction.

Authors:  Ilya Potapov; Joonas Latukka; Jiyeong Kim; Perttu Luukko; Katriina Aalto-Setälä; Esa Räsänen
Journal:  Sci Rep       Date:  2018-10-09       Impact factor: 4.379

8.  Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes.

Authors:  Elijah R Behr; Marylyn D Ritchie; Toshihiro Tanaka; Stefan Kääb; Dana C Crawford; Paola Nicoletti; Aris Floratos; Moritz F Sinner; Prince J Kannankeril; Arthur A M Wilde; Connie R Bezzina; Eric Schulze-Bahr; Sven Zumhagen; Pascale Guicheney; Nanette H Bishopric; Vanessa Marshall; Saad Shakir; Chrysoula Dalageorgou; Steve Bevan; Yalda Jamshidi; Rachel Bastiaenen; Robert J Myerburg; Jean-Jacques Schott; A John Camm; Gerhard Steinbeck; Kris Norris; Russ B Altman; Nicholas P Tatonetti; Steve Jeffery; Michiaki Kubo; Yusuke Nakamura; Yufeng Shen; Alfred L George; Dan M Roden
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.